KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Goodwill & Intangibles: 2020-2025

Historic Goodwill & Intangibles for AbCellera Biologics (ABCL) over the last 5 years, with Sep 2025 value amounting to $87.1 million.

  • AbCellera Biologics' Goodwill & Intangibles fell 13.21% to $87.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $87.1 million, marking a year-over-year decrease of 13.21%. This contributed to the annual value of $89.9 million for FY2024, which is 46.55% down from last year.
  • Per AbCellera Biologics' latest filing, its Goodwill & Intangibles stood at $87.1 million for Q3 2025, which was down 1.07% from $88.1 million recorded in Q2 2025.
  • In the past 5 years, AbCellera Biologics' Goodwill & Intangibles ranged from a high of $210.8 million in Q3 2022 and a low of $87.1 million during Q3 2025.
  • For the 3-year period, AbCellera Biologics' Goodwill & Intangibles averaged around $131.4 million, with its median value being $133.5 million (2024).
  • Per our database at Business Quant, AbCellera Biologics' Goodwill & Intangibles surged by 39.96% in 2021 and then slumped by 46.56% in 2025.
  • AbCellera Biologics' Goodwill & Intangibles (Quarterly) stood at $208.8 million in 2021, then fell by 14.12% to $179.3 million in 2022, then fell by 6.18% to $168.2 million in 2023, then plummeted by 46.55% to $89.9 million in 2024, then decreased by 13.21% to $87.1 million in 2025.
  • Its Goodwill & Intangibles stands at $87.1 million for Q3 2025, versus $88.1 million for Q2 2025 and $89.0 million for Q1 2025.